Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report.
This concerns a 57 year old woman operated on in 1988 for a left radical mastectomy due to ductal breast carcinoma and subsequently treated with chemotherapy and Tamoxifen adjuvant. In 1990 a laparo-hystero-oophorectomy was carried out due to uterine fibromas. The woman continued taking Tamoxifen. Two years later a pelvic regeneration appeared, resulting in endometriosis, site of adenomatose hyperplasia and of endometrioid carcinoma GI. This furthermore confirms the importance of a gynecological follow-up for all women treated with Tamoxifen adjuvant therapy.
Bardi
M
M
Department of Gynecology and Obstetrics, S. Isidoro Hospital Trescore Balneario, Bergamo.
Arnoldi
E
E
Pizzocchero
G
G
Pezzica
E
E
Mattioni
D
D
Perotti
M
M
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000601:surgery; D018269:Carcinoma, Endometrioid / Q000209:etiology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004715:Endometriosis / Q000209:etiology* / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007889:Leiomyoma / Q000209:etiology* / Q000601:surgery; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000209:etiology* / Q000601:surgery; D010052:Ovariectomy; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000209:etiology* / Q000601:surgery
D013629:Tamoxifen